Your browser doesn't support javascript.
loading
SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy.
Hope, Thomas A; Antonarakis, Emmanuel S; Bodei, Lisa; Calais, Jeremie; Iravani, Amir; Jacene, Heather; Koo, Phillip J; Morgans, Alicia K; Osborne, Joseph R; Tagawa, Scott T; Taplin, Mary-Ellen; Sartor, Oliver; Morris, Michael J.
Afiliação
  • Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California; thomas.hope@ucsf.edu.
  • Antonarakis ES; University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota.
  • Bodei L; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California.
  • Iravani A; Department of Radiology, University of Washington, Seattle, Washington.
  • Jacene H; Department of Radiology, Brigham and Women's Hospital, and Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Koo PJ; Banner M.D. Anderson Cancer Center, Phoenix, Arizona.
  • Morgans AK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Osborne JR; Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York.
  • Tagawa ST; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Taplin ME; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sartor O; Mayo Clinic, Rochester, Minnesota; and.
  • Morris MJ; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
J Nucl Med ; 64(9): 1417-1423, 2023 09.
Article em En | MEDLINE | ID: mdl-37290800
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2023 Tipo de documento: Article